CAPHOSOL®, a topical oral agent, is a U.S. patented, medical product that lubricates the mucosa and may help to maintain the integrity of the oral cavity through its mineralizing potential. The distinguishing feature of CAPHOSOL is its high concentrations of calcium and phosphate ions. Calcium ions play a crucial role in several aspects of the inflammatory process, the blood clotting cascade, and tissue repair. Phosphate ions may be a valuable supplemental source of phosphates for damaged mucosal surfaces. Oral mucositis is a painful side effect of some cancer therapies that is under estimated and under treated. By starting Caphosol® (supersaturated calcium phosphate rinse) at the start of cancer therapy you can reduce the occurrence, duration and severity of oral mucositis – mouth sores that can make swallowing and continued therapy challenging or impossible. Caphasol is the only mouth rinse that is clinically proven to decrease the incidence and severity of oral mucositis. 1 More than twice as many patients avoided oral mucositis by using Caphosol in the clinical trial. 2 Using Caphosol as directed at the start of cancer therapy will lubricate and clean the mouth, tongue and throat. It loosens tough mucus and prevents build-up in your throat - so you are more comfortable drinking, chewing and speaking.
